Literature DB >> 1448307

Therapy of bacterial sepsis, meningitis and otitis media in infants and children: 1992 poll of directors of programs in pediatric infectious diseases.

P E Klass1, J O Klein.   

Abstract

To determine current opinions among experts in pediatric infectious diseases for treatment of bacterial sepsis, meningitis and acute otitis media, we polled directors of training programs in January, 1992. Responses were received from 69 centers in the United States and Canada. For initial treatment of presumed bacterial meningitis, the third generation cephalosporins alone or combined with ampicillin have become drugs of choice in all age groups. Most infectious disease programs include dexamethasone in the management of presumed bacterial meningitis for children 2 months of age and older. Third generation cephalosporins are also drugs of choice for presumed sepsis: combined with ampicillin for infants 5 weeks of age; used alone for children 5 months and 12 years of age. Amoxicillin remains the preferred drug for initial treatment of acute otitis media. The combination of amoxicillin and clavulanic acid is favored in the setting of an increased proportion of beta-lactamase-producing bacterial pathogens. Comparison of these results with polls in 1987 and 1989 indicates a shift in recommendations of therapy of presumed bacterial sepsis and meningitis from ampicillin alone or combined with an aminoglycoside or chloramphenicol to use of a third generation cephalosporin alone or combined with ampicillin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1448307     DOI: 10.1097/00006454-199209000-00005

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  7 in total

1.  Bacterial Meningitis.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-05       Impact factor: 3.598

2.  Development of interpretive criteria and quality control limits for broth microdilution and disk diffusion antimicrobial susceptibility testing of Streptococcus pneumoniae.

Authors:  J H Jorgensen; J M Swenson; F C Tenover; M J Ferraro; J A Hindler; P R Murray
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

3.  Bacterial meningitis in the first three months of life.

Authors:  F A Riordan; A P Thomson; J A Sills; C A Hart
Journal:  Postgrad Med J       Date:  1995-01       Impact factor: 2.401

Review 4.  Antibiotics in neonatal infections: a review.

Authors:  V Fanos; A Dall'Agnola
Journal:  Drugs       Date:  1999-09       Impact factor: 9.546

5.  Detection of penicillin and extended-spectrum cephalosporin resistance among Streptococcus pneumoniae clinical isolates by use of the E test.

Authors:  J H Jorgensen; M J Ferraro; M L McElmeel; J Spargo; J M Swenson; F C Tenover
Journal:  J Clin Microbiol       Date:  1994-01       Impact factor: 5.948

6.  Dexamethasone and antibiotics for the empirical treatment of bacterial meningitis in Canadian children: A survey of paediatric infectious diseases specialists.

Authors:  Bjk Tan; Hd Davies
Journal:  Paediatr Child Health       Date:  2002-07       Impact factor: 2.253

7.  Prospective randomized comparison of cefepime and cefotaxime for treatment of bacterial meningitis in infants and children.

Authors:  X Sáez-Llorens; E Castaño; R García; C Báez; M Pérez; F Tejeira; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.